Dow Jones
38.460,92 -42,77 (-0,11%) Nasdaq
15.712,75 +16,11 (+0,10%) Nikkei 225
37.677,40 -782,68 (-2,03%) EUR/USD
1,0712 +0,0011 (+0,11%) Bitcoin EUR
59.963,52 -2.644,62 (-4,22%) CMC Crypto 200
1.390,28 -33,82 (-2,37%)
Cardinal Health, Inc. (CAH)
Dopo ore:
| Chiusura precedente | 103,37 |
| Aperto | 103,18 |
| Denaro | 0,00 x 1200 |
| Lettera | 0,00 x 1200 |
| Min-Max giorno | 102,43 - 103,95 |
| Intervallo di 52 settimane | 77,56 - 116,04 |
| Volume | |
| Media Volume | 2.374.985 |
| Capitalizzazione | 25,184B |
| Beta (5 anni mensile) | 0,70 |
| Rapporto PE (ttm) | 41,09 |
| EPS (ttm) | 2,52 |
| Prossima data utili | 02 mag 2024 |
| Rendimento e dividendo (futuro) | 2,00 (1,93%) |
| Data ex dividendo | 28 mar 2024 |
| Stima target 1A | 115,21 |
GlobeNewswirePrivia Health Announces Changes to Board of Directors
Distinguished Healthcare Leader Dave Wichmann and Seasoned CHRO Pam Kimmet to Join BoardARLINGTON, Va., July 31, 2023 (GLOBE NEWSWIRE) -- Privia Health Group, Inc. (Nasdaq: PRVA) today announced the election of David S. Wichmann and Pamela O. Kimmet to its Board of Directors, effective August 1, 2023. Jeff Bernstein, Managing Director of Goldman Sachs, will resign from the Board effective August 1, 2023, following Goldman Sachs’ sale of its ownership position in Privia Health through a secondary
GlobeNewswireSotera Health Announces Jon Lyons as New Senior Vice President and Chief Financial Officer
CLEVELAND, June 26, 2023 (GLOBE NEWSWIRE) -- Sotera Health Company (Nasdaq: SHC), a leading global provider of mission-critical end-to-end sterilization solutions and lab testing and advisory services for the healthcare industry, announced that Jon Lyons has joined the Company, effective today, as Senior Vice President and Chief Financial Officer (“CFO”). Mr. Lyons recently served as Vice President, Corporate FP&A for Owens Corning (NYSE: OC), a nearly $10 billion global building and constructio
GlobeNewswireAutolus Therapeutics Selects Cardinal Health as U.S. Commercial Distribution Partner
Cardinal Health to provide core distribution capabilities required for U.S. commercialization of CAR T-cell therapiesInnovative Depot Model intended to reduce delivery time by allowing for transit while product release is finalized LONDON, April 27, 2023 (GLOBE NEWSWIRE) -- Autolus Therapeutics plc (Nasdaq: AUTL), a clinical-stage biopharmaceutical company developing next-generation programmed T cell therapies, today announced it has selected Cardinal Health Inc. (NYSE: CAH) to support the launc
